Sanifit Therapeutics, a Spain-based developer of treatments for vascular calcification disorders spun out of University of the Balearic Islands, has been bought by pharmaceutical group Vifor Pharma for €205m ($231m) upfront that could be expanded by up to €170m in clinical, regulatory and market access milestone payments. Sanifit had raised $149m as of a $62.8m…
Exits: November 24, 2021
Nov 24, 2021 • Thierry Heles
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024